SCHEMBL1461637

SCHEMBL1461637

c1cn(CC2CNCC[N]2)cn1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2B6 P20813 1/20 0.44
TBXAS1 P24557 4/20 0.35
CYP11B1 P15538 5/20 0.35
CYP11B2 P19099 4/20 0.35
CYP19A1 P11511 3/20 0.33
ALDH1A1 P00352 1/20 0.33
FDPS P14324 2/20 0.32
GGPS1 O95749 2/20 0.31
BTN3A1 O00481 1/20 0.31
CA12 O43570 1/20 0.31
CA2 P00918 1/20 0.31
LMNA P02545 1/20 0.31
MMP2 P08253 1/20 0.31
MMP9 P14780 1/20 0.31
MMP8 P22894 1/20 0.31
MMP14 P50281 1/20 0.31
CA9 Q16790 1/20 0.31
CA14 Q9ULX7 1/20 0.31
EGLN3 Q9H6Z9 1/20 0.31
CYP1A2 P05177 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1461288 0.84 TBXAS1 (0.44) TBXAS1CYP19A1EGLN3QPCT
SCHEMBL7664060 0.73 CYP2B6 (0.59) CYP2B6TBXAS1CYP11B1CYP11B2CYP19A1
SCHEMBL14254668 0.73 CYP2B6 (0.59) CYP2B6TBXAS1CYP11B1CYP11B2CYP19A1
SCHEMBL14254664 0.73 CYP2B6 (0.59) CYP2B6TBXAS1CYP11B1CYP11B2CYP19A1
Hydrochloric Acid SCHEMBL17048494 0.72 CYP2B6 (0.57) CYP2B6TBXAS1CYP11B1CYP11B2CYP19A1
SCHEMBL13736636 0.72 CYP2B6 (0.61) CYP2B6TBXAS1CYP11B1CYP11B2CYP19A1
SCHEMBL14254658 0.71 CYP2B6 (0.65) CYP2B6TBXAS1CYP19A1
SCHEMBL2961712 0.71 CYP2B6 (0.65) CYP2B6TBXAS1CYP19A1
SCHEMBL2961709 0.71 CYP2B6 (0.65) CYP2B6TBXAS1CYP19A1
Hydrochloric Acid SCHEMBL6787917 0.71 CYP2B6 (0.44) CYP2B6TBXAS1CYP11B1CYP11B2CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120214798-A1 Novel Ethanediamone Hepcidine Antagonists VIFOR (INTERNATIONAL) AG (CH) 2012-08-23 US disclosed
EP-2475643-A1 NOVEL ETHANE DIAMINE HEPCIDIN ANTAGONISTS VIFOR (INTERNATIONAL) AG (CH) 2012-07-18 EP disclosed
WO-2011026959-A1 NOVEL ETHANE DIAMINE HEPCIDIN ANTAGONISTS VIFOR (INTERNATIONAL) AG (CH) 2011-03-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120214798-A1 Novel Ethanediamone Hepcidine Antagonists HAMP, SLC40A1, FTH1 CYP2B6 1346/4885TBXAS1 1451/4885CYP11B1 423/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.